Prasugrel, Aspirin

Prasugrel and aspirin are medications used together to prevent blood clots from forming in patients with cardiovascular diseases. Prasugrel, a thienopyridine, works by inhibiting the action of platelets, which are cell fragments in the blood that can cause clots when they stick together. Aspirin, a widely-known nonsteroidal anti-inflammatory drug (NSAID), also inhibits platelet aggregation.
This combination medication is primarily used in patients who have recently undergone a percutaneous coronary intervention (PCI), such as angioplasty or stent placement. By reducing the risk of blood clots, the therapy can help prevent complications such as heart attack and stroke.
The dual therapy of prasugrel and aspirin should be prescribed under careful consideration, as aspirin may cause side effects such as gastrointestinal bleeding. Healthcare professionals must weigh the benefits and risks before administering this medication to patients with cardiovascular diseases. Regular monitoring is necessary to ensure the medication’s efficacy and to detect any potential side effects.